Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. classroom_web.jpg
    04 October '21

    Introduction to Regulatory Affairs 2021

    Brussel

    The course is addressed to people new to regulatory affairs who want to acquire a comprehensive foundation; to regulatory professionals wishing to update their knowledge, and to all collaborators working in close relationship with regulatory affairs and wishing to understand the role of the department.

  2. classroom.jpg
    02 December '21

    Advanced Course CTD module 3 - Quality section 2021

    Diegem

    This two-day course is intended to provide an in depth knowledge and understanding of the main principles and concepts of the Quality part of the Common Technical Document. 

Show all meetings

News

  1. September 16, 2021

    IFAPP Today newsletter

    Source: IFAPP

    Please find here the link to the IFAPP TODAY newsletter of September 2021.

    Read more

  2. September 10, 2021

    Coronavirus: biweekly update of COVID-19 vaccines 9 September 2021

    Coronavirus: tweewekelijks overzicht bijwerkingen COVID-19-vaccins van 9 september 2021

    Coronavirus : aperçu bimensuel des effets indésirables des vaccins contre la COVID-19 du 9 septembre 2021

    Source: FAMHP

    Read more

  3. September 9, 2021

    Coronavirus: details of the renewed measures taken by the FAMHP to avoid shortages of medicines.

    Het FAGG heeft een aantal maatregelen hernomen in een nieuw ministerieel besluit. Dit besluit werd opgesteld naar aanleiding van de crisiswet van 13 juni 2021 en om tekorten aan geneesmiddelen in het kader van de coronaviruspandemie (COVID-19) te kunnen blijven vermijden.

    L'AFMPS a repris un certain nombre de mesures dans un nouvel arrêté ministériel. Cette décision a été élaborée à la suite de la loi du 13 juin 2021 et pour continuer à éviter les pénuries de médicaments dans le cadre de la pandémie de coronavirus (COVID-19).

    Source: FAMHP

    Read more

We thank our partners for their support. Click on the logos for more information:
 
digidyco_clinical esolutions_gr_web2.png QbD_logo_RGB_300dpi logo Hebias web.png Modis 440x320 nieuwsbrief.jpg
jsn_logo_jj_vert_color_rgb.jpg 20201210 AxTalis Logo MAx MA.jpg SCIENCETALENTS_LOGO_RGB_POS.png Brookwood Global-website.png